Effects of Vivatlac Synbiotic on Gut Micribiota of IBS Patients

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
Multi-center, randomized, double-blind, placebo-controlled, 12 weeks trial investigating the effects of a nine-strain synbiotic (Vivatlac Synbiotikum) on the gut microbiota of IBS patients
Epistemonikos ID: e21bb68716ce7453b9cc1e4675cf176165c93d91
First added on: Nov 20, 2025